Blog
RSS FeedPosted by Michael Wonder on 15 Jan 2020
Proposal to fund betamethasone dipropionate with calcipotriol (Enstilar) foam spray for psoriasis
15 January 2020 - PHARMAC is seeking feedback on a proposal to fund a new topical psoriasis medicine, betamethasone dipropionate ...
Posted by Michael Wonder on 06 Jan 2020
PBAC goes PC
20 December 2019 - PBAC responds to a minor submission from National Aboriginal Community Controlled Health Organisation. ...
Posted by Michael Wonder on 03 Jan 2020
Aerie Pharmaceuticals announces acceptance for review of the Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% marketing authorisation application in Europe
2 January 2020 - Aerie Pharmaceuticals today announced that the EMA has accepted for review the marketing authorisation application for Roclanda ...
Posted by Michael Wonder on 24 Dec 2019
AstraZeneca’s triple-combination therapy approved in China for patients with COPD
23 December 2019 - First fixed-dose triple-combination therapy in a pressurised metered-dose inhaler device in China. ...
Posted by Michael Wonder on 22 Dec 2019
ViiV Healthcare receives complete response letter from US FDA for use of investigational cabotegravir and rilpivirine long-acting regimen in the treatment of HIV
21 December 2019 - ViiV Healthcare, with Pfizer and Shionogi, has received a complete response letter from the US FDA regarding ...
Posted by Michael Wonder on 12 Dec 2019
Decision to award sole supply for fluticasone and fluticasone with salmeterol metered dose inhalers
12 December 2019 - PHARMAC has made a decision to make changes to the funded brands of fluticasone and fluticasone ...
Posted by Michael Wonder on 10 Dec 2019
Pickering mom fights for life-changing CF medicine to come to Canada
10 December 2019 - Stephanie Stavros feels like she's 'screaming into an abyss' as her life slips away. ...
Posted by Michael Wonder on 04 Dec 2019
Health Canada grants priority review status for Heron Therapeutics' new drug submission for HTX-011 for management of post-operative pain
3 December 2019 - Heron Therapeutics today announced that Heron's new drug submission for HTX-011 for the management of postoperative pain ...
Posted by Michael Wonder on 04 Dec 2019
Aerie Pharmaceuticals submits marketing authorisation application for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in Europe
3 December 2019 - Aerie Pharmaceuticals today announced that it has submitted the marketing authorisation application for Roclanda (netarsudil and latanoprost ...
Posted by Michael Wonder on 02 Dec 2019
Tasmanian man Robert Mitchell welcomes rollout of new drug Dovato on PBS
2 December 2019 - Robert Mitchell has been defying a medical diagnosis for nearly 30 years. Now a new drug will ...
Posted by Michael Wonder on 28 Nov 2019
Sosei Heptares announces that the COPD treatment Ultibro Breezhaler has been included in the National Reimbursement Drug List in China
28 November 2019 - Sosei Group announces that Ultibro Breezhaler (an inhaled once-daily fixed-dose combination of indacaterol/glycopyrronium bromide) has been included ...
Posted by Michael Wonder on 28 Nov 2019
Hikma completes its FDA response for generic Advair
27 November 2019 - Hikma Pharmaceuticals today announces that it has submitted to the US FDA its response to deficiencies in ...
Posted by Michael Wonder on 26 Nov 2019
World AIDS Day 1 December 2019 – more support for Australians living with HIV
27 November 2019 - World AIDS Day is held on 1 December each year. It raises awareness across the world and ...
Posted by Michael Wonder on 26 Nov 2019
Canberra to increase HIV funding, list groundbreaking drug treatment
27 November 2019 - Australia's bid to be among the first countries in the world to eliminate HIV transmissions will ...
Posted by Michael Wonder on 22 Nov 2019
Health Canada approves Lonsurf (trifluridine/tipiracil) for adults with metastatic gastric cancer during stomach cancer awareness month
21 November 2019 - New indication improves overall survival for end stage metastatic disease ...